Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Line 10: Line 10:
<div style="float:left; width:72%"> <!-- This width add to the the margin below to equal 99%-->
<div style="float:left; width:72%"> <!-- This width add to the the margin below to equal 99%-->
-
 
-
 
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal
|<!-- TITLE OF BOX -->
|<!-- TITLE OF BOX -->

Revision as of 18:02, 3 October 2017

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

Hippo-Merlin signaling dysregulation (Homo sapiens)

Image does not exist
Hippo-Merlin signaling dysregulation
Evading growth suppressors

TGF-beta signaling (Homo sapiens)

Image does not exist
TGF-beta signaling
Activating invasion and metastasis

Epithelial to mesenchymal transition in colorectal cancer (Homo sapiens)

Image does not exist
Epithelial to mesenchymal transition in colorectal cancer
Enabling replicative immortality

Regulation of Wnt / B-catenin signaling by small molecule compounds (Homo sapiens)

Image does not exist
Regulation of Wnt / B-catenin signaling by small molecule compounds
Inducing angiogenesis

Angiogenesis (Homo sapiens)

Image does not exist
Angiogenesis
Resisting cell death

miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)

Image does not exist
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics

TCA cycle nutrient use and invasiveness of ovarian cancer (Homo sapiens)

Image does not exist
TCA cycle nutrient use and invasiveness of ovarian cancer
Genome instability and mutation

DNA IR-double strand breaks and cellular response via ATM (Homo sapiens)

Image does not exist
DNA IR-double strand breaks and cellular response via ATM
Tumor promoting inflammation

Chemokine signaling (Homo sapiens)

Image does not exist
Chemokine signaling
Avoiding immune destruction

Interferon type I signaling (Homo sapiens)

Image does not exist
Interferon type I signaling
Therapeutics

lncRNA-mediated mechanisms of therapeutic resistance (Homo sapiens)

Image does not exist
lncRNA-mediated mechanisms of therapeutic resistance

edit  

Featured Pathways

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools